Trial Profile
Double Blind, Randomised, Cross-over Study Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2022
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Therapeutic Use
- 12 Jul 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 13 Jun 2011 New trial record